Roche, Evotec in licensing deal for Alzheimer's treatments

01/10/2006 | Reuters

Roche and German biotech company Evotec signed a licensing deal for two Roche compounds in Phase I clinical development for treating Alzheimer's disease. Roche will receive upfront fees, milestone payments and royalties on any product sales and retain a late-stage co-development option on the two compounds.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA